Cytotoxicity and osteogenic potential of silicate calcium cements as potential protective materials for pulpal revascularization

A favorable tissue response is anticipated to occur with the use of Biodentine as a blood clot-protecting material for pulpal revascularization. Further investigations with the use of in vivo animal models are required to validate the potential adverse biological effects of TheraCal LC on hDPSCs.